glyburide has been researched along with betadex in 8 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (12.50) | 18.2507 |
| 2000's | 2 (25.00) | 29.6817 |
| 2010's | 5 (62.50) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Babu, RJ; Pandit, JK | 1 |
| Cheng, KS; Li, CL; Lin, MW; Ting, WH; Wu, AZ; Wu, SN | 1 |
| Buchanan, CM; Buchanan, NL; Edgar, KJ; Klein, S; Lambert, JL; Ramsey, MG; Wempe, MF; Zoeller, T | 1 |
| Gowthamarajan, K; Prakash, D; Singare, DS; Singh, SK; Srinivasan, KK | 1 |
| Dressman, JB; Klein, S; Zoeller, T | 1 |
| Font, M; Irache, JM; Lucio, D; Martínez-Ohárriz, MC | 2 |
| González-Gaitano, G; González-Navarro, CJ; Irache, JM; Lucio, D; Martínez-Ohárriz, MC; Navarro-Herrera, D; Radulescu, A | 1 |
8 other study(ies) available for glyburide and betadex
| Article | Year |
|---|---|
Effect of aging on the dissolution stability of glibenclamide/beta-cyclodextrin complex.
Topics: beta-Cyclodextrins; Chemical Phenomena; Chemistry, Physical; Cyclodextrins; Drug Stability; Glyburide; Solubility; Solutions; Spectrophotometry, Infrared; Tablets; Time Factors; X-Ray Diffraction | 1999 |
Changes in membrane cholesterol of pituitary tumor (GH3) cells regulate the activity of large-conductance Ca2+-activated K+ channels.
Topics: Action Potentials; Animals; Apamin; beta-Cyclodextrins; Caffeic Acids; Calcium; Cholesterol; Cilostazol; Dexamethasone; Diazoxide; Glyburide; Indoles; Ion Channel Gating; Large-Conductance Calcium-Activated Potassium Channels; Membrane Lipids; Phenylethyl Alcohol; Pituitary Neoplasms; Rats; Tetrazoles; Tumor Cells, Cultured | 2006 |
Improving glyburide solubility and dissolution by complexation with hydroxybutenyl-beta-cyclodextrin.
Topics: beta-Cyclodextrins; Capsules; Chemical Phenomena; Chemistry, Pharmaceutical; Chromatography, High Pressure Liquid; Differential Thermal Analysis; Gastric Juice; Gelatin; Glyburide; Hydrogen-Ion Concentration; Pharmaceutical Preparations; Solubility; Technology, Pharmaceutical; Temperature | 2009 |
Formulation of ternary complexes of glyburide with hydroxypropyl-β-cyclodextrin and other solubilizing agents and their effect on release behavior of glyburide in aqueous and buffered media at different agitation speeds.
Topics: 2-Hydroxypropyl-beta-cyclodextrin; beta-Cyclodextrins; Buffers; Calorimetry, Differential Scanning; Drug Compounding; Glyburide; Hydrogen-Ion Concentration; Hypoglycemic Agents; Kinetics; Pharmaceutic Aids; Phase Transition; Solubility; Stress, Mechanical; Tablets; Time Factors; Water; X-Ray Diffraction | 2012 |
Application of a ternary HP-β-CD-complex approach to improve the dissolution performance of a poorly soluble weak acid under biorelevant conditions.
Topics: 2-Hydroxypropyl-beta-cyclodextrin; Animals; beta-Cyclodextrins; Biological Availability; Calorimetry, Differential Scanning; Chemistry, Pharmaceutical; Dosage Forms; Drug Compounding; Excipients; Glyburide; Humans; Hydrogen-Ion Concentration; Hypoglycemic Agents; Kinetics; Polyvinyls; Povidone; Solubility; Technology, Pharmaceutical | 2012 |
Nanoaggregation of inclusion complexes of glibenclamide with cyclodextrins.
Topics: Administration, Oral; beta-Cyclodextrins; Biological Availability; Drug Stability; Glyburide; Hydrogen; Nanoparticles; Solubility | 2017 |
Supramolecular structure of glibenclamide and β-cyclodextrins complexes.
Topics: beta-Cyclodextrins; Calorimetry, Differential Scanning; Cyclodextrins; Glyburide; Models, Molecular; Solubility; X-Ray Diffraction | 2017 |
Coencapsulation of cyclodextrins into poly(anhydride) nanoparticles to improve the oral administration of glibenclamide. A screening on C. elegans.
Topics: Administration, Oral; Animals; beta-Cyclodextrins; Caenorhabditis elegans; Drug Carriers; Drug Compounding; Drug Liberation; Glyburide; Hypolipidemic Agents; Kinetics; Lipid Metabolism; Lipids; Nanoparticles; Particle Size; Polyanhydrides | 2018 |